Public Cord Blood Banks as a source of starting material for clinical grade HLA-homozygous induced pluripotent stem cells

BACKGROUND: The increasing number of clinical trials for induced pluripotent stem cell (iPSC)-derived cell therapy products makes the production on clinical grade iPSC more and more relevant and necessary. Cord blood banks are an ideal source of young, HLA-typed and virus screened starting material...

Descripción completa

Detalles Bibliográficos
Autores principales: Álvarez-Palomo, Belén, Veiga, Anna, Raya, Angel, Codinach, Margarita, Torrents, Silvia, Ponce Verdugo, Laura, Rodriguez-Aierbe, Clara, Cuellar, Leopoldo, Alenda, Raquel, Arbona, Cristina, Hernández-Maraver, Dolores, Fusté, Cristina, Querol, Sergi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372949/
https://www.ncbi.nlm.nih.gov/pubmed/35962457
http://dx.doi.org/10.1186/s13287-022-02961-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372949/
https://www.ncbi.nlm.nih.gov/pubmed/35962457
http://dx.doi.org/10.1186/s13287-022-02961-6

Ejemplares similares